AUS
NZ
UK
CA
USA
IND
Healthcare
Resilience in Focus: CSL and ResMed Stand Out Amid Tariff Concerns
April 15, 2025 02:13 PM AEST| By Team Kalkine MediaHighlights,CSL and ResMed seen as strong performers under tariff pressures,Healthcare stocks show strength during past market downturns,Fundamental growth supports CSL and ResMed’s long-term positioning,As global markets prepare for the potential imp...
ASX Inches Up as Miners and Tech Lift Market Amid Global Uncertainty
April 15, 2025 12:36 PM AEST| By Team Kalkine MediaHighlights,ASX 200 sees mild gains despite choppy session,Mining and tech stocks lead the upward move,Caution lingers due to US tariff policy concerns,The Australian sharemarket saw a modest rise in early trade, continuing to navigate a cautious envi...
Clarity Pharmaceuticals (ASX:CU6) Advances Cancer Therapy with Phase II Trial Milestone
April 15, 2025 12:31 PM AEST| By Team Kalkine MediaHighlights,Clarity Pharmaceuticals begins Phase II cohort expansion in,SECuRE,trial,First patient treated with 8,GBq,dose of improved radiopharmaceutical,New formulation enhances stability and scalability for future trials,Clarity Pharmaceuticals (AS...
4DMedical Expands Reach with New Commercial Contract for Lung Imaging Technology
April 15, 2025 12:29 PM AEST| By Team Kalkine MediaHighlights,4DMedical signs new commercial contract with Integral Diagnostics,Advanced lung imaging tech expands to more clinics across Victoria,Continued success converting pilots into commercial deals,4DMedical (ASX:4DX), a leading innovator in medi...
ASX Market Close: Elixir Surges with Neil Young's Resignation; US Futures Show Growth & More
April 14, 2025 05:30 PM AEST| By Team Kalkine MediaHighlights,Technology sector on the ASX leads with strong gains following positive trends from international markets.,Materials sector shows growth due to rising commodity prices, particularly iron ore and gold.,Key companies like Droneshield, Neuren...
Orthocell Ltd Advances with FDA Clearance for Remplir™ and Market Expansion
April 14, 2025 04:21 PM AEST| By Team Kalkine MediaHighlights,FDA clearance granted for Orthocell’s Remplir™ nerve repair device, facilitating entry into the nerve repair market.,Significant growth in revenue with expanded manufacturing capabilities for global distribution.,Orthocell added to the S&P...
Visionflex Partners with Amplar on $1M Telehealth Initiative to Revolutionise Aged Care Access
April 14, 2025 12:34 PM AEST| By Team Kalkine MediaHighlights,Visionflex,and,Amplar,launch $1m telehealth initiative for aged care,Pilot to serve 30 residential aged care homes across Australia,Focus on virtual nursing and,personalised,clinical care,Visionflex Group (ASX:VFX) has announced a strategi...
FDA Green Light Sparks Global Momentum for Orthocell’s Remplir™ Nerve Repair Device
April 14, 2025 12:31 PM AEST| By Team Kalkine MediaHighlights,FDA clearance sets stage for U.S. entry into $1.6B nerve repair market,Manufacturing scaled to meet growing global demand,Strong cash reserves support expansion without extra funding,Orthocell (ASX:OCC) is entering a pivotal phase of growt...
Neuren’s Next Big Step: FDA Clears Phase 3 Trial for Rare Disorder Treatment
April 14, 2025 12:30 PM AEST| By Team Kalkine MediaHighlights,FDA clears path for Phase 3 trial in rare genetic disorder,Neuren's NNZ-2591 set for double-blind testing,Industry momentum grows for rare disease treatments,Neuren Pharmaceuticals (ASX:NEU) is making a significant stride in its drug devel...
Emyria Expands Access to Psychedelic-Assisted Therapy with New Centre Launch in Perth
April 14, 2025 11:31 AM AEST| By Team Kalkine MediaHighlights,Emyria opens second mental health centre in Perth,Fully funded patient treatments begin,Plans aligned for national expansion,Emyria Ltd (ASX:EMD) is making significant strides in Australia’s mental health sector with the expansion of its p...
Insiders Signal Confidence: Multiple Leaders Invest in SomnoMed Shares
April 14, 2025 11:29 AM AEST| By Team Kalkine MediaHighlights,Multiple insiders recently,acquired,shares in,SomnoMed,Largest insider purchase valued at AU$295k,Insider ownership stands at 7% of the company,Insider activity often offers unique insights into a company’s internal confidence. In the case...
Neuren Pharmaceuticals Surges as FDA Greenlights Key Phase 3 Trial
April 14, 2025 11:25 AM AEST| By Team Kalkine MediaHighlights,Neuren,gains FDA nod for crucial Phase 3 trial,Trial targets rare neurological disorder in children,Shares jump over 18% in early ASX trading,Shares of,Neuren Pharmaceuticals (ASX:NEU),rallied strongly on Monday, outperforming the broader...
Visionflex Teams Up with Amplar Health in $1 Million Virtual Nursing Initiative
April 14, 2025 11:21 AM AEST| By Team Kalkine MediaHighlights,Visionflex,to deploy virtual nursing tech across aged care homes,$1 million contract spans hardware and software solutions,Project targets rural and culturally diverse communities,Visionflex Group Limited (ASX:VFX) has announced a binding...
Cryosite’s Chairman Ups Stake: A Closer Look at Insider Moves (ASX:CTE)
April 14, 2025 11:03 AM AEST| By Team Kalkine MediaHighlights,Cryosite’s,chairman,increases stake with recent purchase,Insider ownership,remains,significantly high at 61%,Mixed signals from past 12 months of insider activity,Cryosite Limited (ASX:CTE) has caught the attention of market watchers follo...
Genetic Signatures Limited (ASX:GSS) Could Be Fairly Valued Despite a 30% Drop
April 12, 2025 12:30 PM AEST| By Team Kalkine MediaHighlights,Genetic Signatures (GSS) sees significant stock price decline.,Revenue growth outlook strong despite industry trends.,Market skepticism evident despite positive forecasts.,The journey has been rough for Genetic Signatures Limited (ASX:GSS)...
Insider Dynamics of Monash IVF Group Limited (ASX:MVF)
April 12, 2025 12:30 PM AEST| By Team Kalkine MediaHighlights,Insider trades reveal confidence in Monash IVF despite share price drop.,Catherine Aston's significant stock purchase signals a positive outlook.,Monash IVF insiders own 1.2% of the company's shares, worth AU$3.4m.,In the world of investme...
4DMedical’s Lung Imaging Tech Gains Global Traction in Breakthrough Respiratory Trials
April 11, 2025 12:43 PM AEST| By Team Kalkine MediaHighlights,4DMedical partners with global firms on advanced lung disease therapies.,Software to support clinical trials for COPD and implantable lung,device,.,U.S. veterans’ healthcare initiative integrates 4DMedical’s diagnostic tech.,4DMedical’s (A...
EBOS Group Secures $200M to Boost Global Expansion Plans
April 11, 2025 12:12 PM AEST| By Team Kalkine MediaHighlights,EBOS raises $200 million through equity placement,Funds to support recent acquisitions and growth,Additional $50 million targeted via retail offer,Healthcare and animal care products distributor EBOS Group (ASX:EBO) has successfully raised...
Legal Heat Intensifies: Mayne Pharma Faces Contract Dispute Over 2022 Licensing Deal
April 11, 2025 10:59 AM AEST| By Team Kalkine MediaHighlights,Mayne Pharma embroiled in legal dispute with TherapeuticsMD,Allegations tied to a $153M women’s health portfolio deal,Legal claims include breach of contract and unjust enrichment,Mayne Pharma (ASX:MYX) is under scrutiny following legal ac...
Is Investing in Trajan Group Holdings (ASX:TRJ) Considered Risky?
April 11, 2025 10:30 AM AEST| By Team Kalkine MediaHighlights,Examines Trajan Group Holdings' debt and financial health.,Highlights importance of managing liabilities without dilution.,Discusses risk factors related to Trajan Group's debt holdings.,Legendary fund manager Li Lu, famously backed by Cha...
Advertise your brand on Kalkine Media